384 related articles for article (PubMed ID: 19363851)
1. Biologic survival.
Noiles K; Vender R
J Drugs Dermatol; 2009 Apr; 8(4):329-33. PubMed ID: 19363851
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
Reich K; Burden AD; Eaton JN; Hawkins NS
Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapy in psoriasis: perspectives on associated risks and patient management.
Papp KA; Dekoven J; Parsons L; Pirzada S; Robern M; Robertson L; Tan JK
J Cutan Med Surg; 2012; 16(3):153-68. PubMed ID: 22713438
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study.
Viguier M; Pagès C; Aubin F; Delaporte E; Descamps V; Lok C; Beylot-Barry M; Séneschal J; Dubertret L; Morand JJ; Dréno B; Bachelez H;
Br J Dermatol; 2012 Aug; 167(2):417-23. PubMed ID: 22413927
[TBL] [Abstract][Full Text] [Related]
5. Biologic therapies for psoriasis. A systematic review.
Boehncke WH; Prinz J; Gottlieb AB
J Rheumatol; 2006 Jul; 33(7):1447-51. PubMed ID: 16724367
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of biologic therapies for plaque psoriasis.
Ahn CS; Gustafson CJ; Sandoval LF; Davis SA; Feldman SR
Am J Clin Dermatol; 2013 Aug; 14(4):315-26. PubMed ID: 23696234
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States.
Anis AH; Bansback N; Sizto S; Gupta SR; Willian MK; Feldman SR
J Dermatolog Treat; 2011 Apr; 22(2):65-74. PubMed ID: 20443663
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.
Gniadecki R; Bang B; Bryld LE; Iversen L; Lasthein S; Skov L
Br J Dermatol; 2015 Jan; 172(1):244-52. PubMed ID: 25132294
[TBL] [Abstract][Full Text] [Related]
9. Advancements in the treatment of psoriasis: role of biologic agents.
Rich SJ; Bello-Quintero CE
J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
[TBL] [Abstract][Full Text] [Related]
10. Combining traditional agents and biologics for the treatment of psoriasis.
Cather JC; Menter A
Semin Cutan Med Surg; 2005 Mar; 24(1):37-45. PubMed ID: 15900797
[TBL] [Abstract][Full Text] [Related]
11. Erythrodermic psoriasis: current and future role of biologicals.
Stinco G; Errichetti E
BioDrugs; 2015 Apr; 29(2):91-101. PubMed ID: 25752640
[TBL] [Abstract][Full Text] [Related]
12. [Biologic therapies in the treatment of psoriasis].
Farhi D; Dupin N
Presse Med; 2009 May; 38(5):832-43. PubMed ID: 19282134
[TBL] [Abstract][Full Text] [Related]
13. Biologic agents in the treatment of psoriasis.
Guarneri F; Guarneri C; Guarneri B
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):193-217. PubMed ID: 19075983
[TBL] [Abstract][Full Text] [Related]
14. Biologic therapeutics in the treatment of psoriasis. Part 1: review.
Langley RG; Gupta AK; Cherman AM; Inniss KA
J Cutan Med Surg; 2007; 11(3):99-122. PubMed ID: 17511926
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.
Signorovitch JE; Betts KA; Yan YS; LeReun C; Sundaram M; Wu EQ; Mulani P
Br J Dermatol; 2015 Feb; 172(2):504-12. PubMed ID: 25288183
[TBL] [Abstract][Full Text] [Related]
16. Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.
Esposito M; Gisondi P; Cassano N; Ferrucci G; Del Giglio M; Loconsole F; Giunta A; Vena GA; Chimenti S; Girolomoni G
Br J Dermatol; 2013 Sep; 169(3):666-72. PubMed ID: 23647206
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of response to biologic treatment: perspective for psoriasis.
Edson-Heredia E; Sterling KL; Alatorre CI; Cuyun Carter G; Paczkowski R; Zarotsky V; Maeda-Chubachi T
J Invest Dermatol; 2014 Jan; 134(1):18-23. PubMed ID: 23921949
[TBL] [Abstract][Full Text] [Related]
18. Use of biologic agents in pediatric psoriasis.
Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
[TBL] [Abstract][Full Text] [Related]
19. Biologicals in the treatment of psoriasis.
Boker A; Kimball AB; Rolz-Cruz G
Curr Opin Investig Drugs; 2007 Nov; 8(11):939-46. PubMed ID: 17979028
[TBL] [Abstract][Full Text] [Related]
20. The effect of weight on the efficacy of biologic therapy in patients with psoriasis.
Clark L; Lebwohl M
J Am Acad Dermatol; 2008 Mar; 58(3):443-6. PubMed ID: 18083274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
